Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamanna Haque

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
JCI Insight|May 24, 2019
PI3 kinase alpha and delta promote hematopoietic stem cell activationShayda Hemmati, Taneisha Sinclair, Meng Tong, et al.
Plant Physiology|January 28, 2017
Identification of Phosphorylation Sites Altering Pollen Soluble Inorganic Pyrophosphatase ActivityDeborah J Eaves, Tamanna Haque, Richard L Tudor, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansionJennifer Yeung, Sophia Y Philbrook, Emma Uible, et al.
Blood Advances|December 6, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failureKuo-Kai Chin, Brian J Ball, Yasmin Abaza, et al.
British Journal of Haematology|December 9, 2024
A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesisTamanna Haque, Aditi Shastri, Pinkal Desai, et al.
Leukemia Research|September 30, 2023
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromesTamanna Haque, Felix López Cadenas, Blanca Xicoy, et al.
British Journal of Haematology|December 3, 2025
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortiumDaniel T Peters, Deedra Nicolet, Yazan F Madanat, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025Peter L Greenberg, Richard M Stone, Yasmin Abaza, et al.
Blood Advances|June 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKsJacob D Soumerai, Meghan C Thompson, Ahmet Dogan, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
JCI Insight|May 24, 2019
PI3 kinase alpha and delta promote hematopoietic stem cell activationShayda Hemmati, Taneisha Sinclair, Meng Tong, et al.
Plant Physiology|January 28, 2017
Identification of Phosphorylation Sites Altering Pollen Soluble Inorganic Pyrophosphatase ActivityDeborah J Eaves, Tamanna Haque, Richard L Tudor, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansionJennifer Yeung, Sophia Y Philbrook, Emma Uible, et al.
Blood Advances|December 6, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failureKuo-Kai Chin, Brian J Ball, Yasmin Abaza, et al.
British Journal of Haematology|December 9, 2024
A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesisTamanna Haque, Aditi Shastri, Pinkal Desai, et al.
Leukemia Research|September 30, 2023
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromesTamanna Haque, Felix López Cadenas, Blanca Xicoy, et al.
British Journal of Haematology|December 3, 2025
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortiumDaniel T Peters, Deedra Nicolet, Yazan F Madanat, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025Peter L Greenberg, Richard M Stone, Yasmin Abaza, et al.
Blood Advances|June 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKsJacob D Soumerai, Meghan C Thompson, Ahmet Dogan, et al.
Pageof 2